Literature DB >> 10432005

Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer.

D L Ornstein1, J MacNab, K H Cohn.   

Abstract

Matrix metalloproteinase 2 (MMP-2) facilitates tumor growth and metastasis in colon cancer. Although tumor cells may produce MMP-2, stromal cells, such as macrophages and fibroblasts, contribute significantly to MMP-2 synthesis in human tumors. We characterized four human colon cancer cell lines with differing biological behavior for MMP-2 expression. While the parent tumors from which the cell lines were derived all expressed MMP-2 mRNA, MMP-2 transcripts were detected in only one cell line, TF-17C, which is nontumorigenic in a nude mouse tumor model. TF-43C, which is tumorigenic and metastatic in the same tumor model, did not produce MMP-2, yet the tumors which arose from it after injection into nude mice did contain MMP-2 mRNA, suggesting a contribution from stromal cells. Co-culturing TF-43C with fibroblasts resulted in an increase in MMP-2 protein, whereas co-culturing with the nontumorigenic cell line TF-13Cm did not alter constitutive fibroblast MMP-2 secretion. Conditioned medium from TF-43C cells also stimulated fibroblast MMP-2 production. These data suggest that a soluble factor from TF-43C cells can stimulate fibroblast MMP-2 production and support the hypothesis that colon cancer cell interactions with stromal fibroblasts may be important determinants of tumor behavior in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432005     DOI: 10.1023/a:1006562818088

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  49 in total

1.  Loss of basement membrane components by invasive tumors but not by their benign counterparts.

Authors:  S H Barsky; G P Siegal; F Jannotta; L A Liotta
Journal:  Lab Invest       Date:  1983-08       Impact factor: 5.662

2.  Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor.

Authors:  Z An; X Wang; N Willmott; S K Chander; S Tickle; A J Docherty; A Mountain; A T Millican; R Morphy; J R Porter; R O Epemolu; T Kubota; A R Moossa; R M Hoffman
Journal:  Clin Exp Metastasis       Date:  1997-03       Impact factor: 5.150

3.  The expression of acylphosphatase is associated with the metastatic phenotype in human colorectal tumors.

Authors:  H D Riley; J Macnab; T J Farrell; K Cohn
Journal:  Carcinogenesis       Date:  1997-12       Impact factor: 4.944

4.  Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.

Authors:  Z S Zeng; Y Huang; A M Cohen; J G Guillem
Journal:  J Clin Oncol       Date:  1996-12       Impact factor: 44.544

5.  Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase.

Authors:  V Shah; S Kumar; K A Zirvi
Journal:  In Vivo       Date:  1994 May-Jun       Impact factor: 2.155

6.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.

Authors:  A Okada; J P Bellocq; N Rouyer; M P Chenard; M C Rio; P Chambon; P Basset
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer.

Authors:  C Pyke; E Ralfkiaer; K Tryggvason; K Danø
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  Tumour basement membrane laminin in adenocarcinoma of rectum: an immunohistochemical study of biological and clinical significance.

Authors:  S J Forster; I C Talbot; D G Clayton; D R Critchley
Journal:  Int J Cancer       Date:  1986-06-15       Impact factor: 7.396

9.  Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase.

Authors:  H Kataoka; R DeCastro; S Zucker; C Biswas
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

10.  Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model.

Authors:  S A Watson; T M Morris; S L Parsons; R J Steele; P D Brown
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

View more
  5 in total

1.  There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions.

Authors:  H Chauhan; A Abraham; J R A Phillips; J H Pringle; R A Walker; J L Jones
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

2.  Balance between activation and inhibition of matrix metalloproteinase-2 (MMP-2) is altered in colorectal tumors compared to normal colonic epithelium.

Authors:  Deborah L Ornstein; Kenneth H Cohn
Journal:  Dig Dis Sci       Date:  2002-08       Impact factor: 3.199

3.  Matrix metalloproteinase-2 and -7 expression in colorectal cancer.

Authors:  Seong Woo Hong; Yun Kyung Kang; Byungmo Lee; Woo Yong Lee; Yeo Gu Jang; In Wook Paik; Hyucksang Lee
Journal:  J Korean Soc Coloproctol       Date:  2011-06-30

4.  Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.

Authors:  H M Collins; T M Morris; S A Watson
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

5.  Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.

Authors:  Mujeeb Zafar Banday; Aga Syed Sameer
Journal:  Biosci Rep       Date:  2019-05-10       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.